Healthcare service provided for headache patients in selected African countries: a cross-sectional survey of clinician perspectives - Summary - MDSpire

Healthcare service provided for headache patients in selected African countries: a cross-sectional survey of clinician perspectives

  • By

  • Amr Hassan

  • Freda Dodd-Glover

  • Najib Kissani

  • Magnerou Annick Melanie

  • Sounga Bandzouzi Prince Eliot Galieni

  • Mendinatou Agbetou

  • Kigocha Okeng'o

  • Daniel Gams Massi

  • Evelyne Diarra

  • Agbo Panzo Cedric

  • Chiamaka Edith Okereke

  • Wael Alwachi

  • Osheik Seidi

  • Kadira Abdi Aden

  • Augustina Charway-Felli

  • Emna Ellouz

  • Foksouna Sakadi

  • John N. Jabang

  • Denis Shatima

  • Athanase Millogo

  • Ahmed Allioueche

  • Fatimata Hassane Djibo

  • Tiwonge Elisa Phiri

  • Jamal Barros Baco

  • Grenaba-Duval Lewis Reinier Joël

  • Frighton Mutete

  • Doaa M. Khalil

  • Mona Hussein

  • July 15, 2026

Share

Objective:

To evaluate the availability, accessibility, and organizational structure of headache care services across African countries and to detect major challenges and barriers to optimal care from the perspective of headache-treating clinicians.

Approach:
  • Study Design: Cross-sectional study involving 73 neurologists from 28 African countries, using a structured online questionnaire.
  • Sampling Strategy: Countries selected based on World Bank income classification to ensure balanced representation across economic strata.
Key Findings:
  • Significant discrepancies in workforce capacity: 10 neurologists per country in low-income countries (LICs) vs. 200 in upper-middle-income countries (UMICs) (p < 0.001).
  • Limited access to headache care in LICs, with 50% reporting a 3–4 week waiting list for consultations, and 41.7% reporting a similar waiting time for imaging (p = 0.028, 0.012).
  • Structural barriers highest in LICs, including limited neuroimaging (91.7%) and financial constraints (83.3%).
  • Essential medications more reimbursed in lower-middle-income and upper-middle-income countries, but innovative therapies (gepants, ditans, and CGRP mAbs) not reimbursed across all settings.
Interpretation:

Headache care across African countries faces substantial inequities in human resources, workforce capabilities, and access to proper care.

Limitations:
  • Response rate of 60.8% may limit the generalizability of findings.
  • Potential biases in self-reported data from clinicians.
Conclusion:

Addressing challenges in headache care requires improving healthcare systems, training non-specialist providers, expanding insurance coverage, and increasing awareness of headache disorders in health policy.

Original Source(s)

Related Content